The biggest private biotech investments in April 2023

Published on May 12, 2023

April 2023 saw the companies Orbital Therapeutics, Sangon Biotech, and Alentis Therapeutics bag the biggest biotech investments of the month. Around the world, oncology, drug discovery, food and biomaterials attracted the biggest funding rounds. With reports of venture capital investments in biotech and pharma hitting a more than three-year low last quarter, private biotech fundraising […]

The post The biggest private biotech investments in April 2023 appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Continue reading on website
Other news

Top 25 Biotech Companies of 2023

May 12, 2023
Lost in all the talk about biotech stocks falling since the markets turned bearish two years ago is that overall, they have performed better than the market as a whole.Many biotech stocks sank deeper than the overall market during the first quarter, as GEN recently reported. But the first quarter (Q1) results were skewed by the banking crisis wrought by the collapses of Silicon Valley Bank and Sig

Convergent Therapeutics to use $90M funding to treat cancer with radiopharmaceuticals 

May 12, 2023
Convergent Therapeutics Inc., a clinical-stage biotechnology company focused on the development of next-generation radiopharmaceuticals for the treatment of cancer, today announced the completion of a $90 million Series A financing. The funding was led by OrbiMed and RA Capital Management with participation from Invus. The financing will support the development of a pipeline of novel […]The post C